急性冠脉综合征的药物研究进展

被引:6
作者
王浩
何作云
机构
[1] 第三军医大学新桥医院心内科
关键词
急性冠状动脉综合征; 药物治疗;
D O I
暂无
中图分类号
R972 [心血管系统药物];
学科分类号
1007 ;
摘要
引用
收藏
页码:465 / 467
页数:3
相关论文
共 21 条
[1]  
The case for inten-sive statin therapyafter acute coronary syndromes. Gregory G,Schwartz,Anders GO. The American Journal of Cardiology . 2005
[2]  
Management of non-ST-elevation acute coronary syndromes how cost-effec-tive are glycoprotein IIb/IIIA antagonists in the UK Na-tional Health Service. Stephen P,Mark S,Zoe P,et al. International Journal of Cardiology . 2005
[3]  
Ran-domised trial of cholesterol lowering in 4444 patientswith coronary heart disease:the Scandinavian Simvasta-tin Survival Study(4S). Scandinavian Simvastatin Survival Study Group. The Lancet . 1994
[4]  
Effects of pretreat-ment with clopidogrel and aspirin followed by long-termtherapy in patients undergoing percutaneous coronary in-tervention:the PCI-CURE study. Mehta S,Yusuf S,Peters R,et al. The Lancet . 2001
[5]  
Effect of glycoprotein IIb/IIIa receptorblocker abciximab on outcome in patients with acutecoronary syndromes without early coronary revascular-isation:the GUSTO IV-ACS randomized trial. Simoons ML. The Lancet . 2001
[6]  
Pharmaco-logic plaque passivation for the reduction of recurrentcardiac events in acute coronary syndromes. Stephen M,Richard AK,Enrique R,et al. Journal of the American College of Cardiology . 2003
[7]  
Exploring the role ofenoxaparin in the management of high-risk patients withnon-ST-elevation acute coronary syndromes:The SYN-ERGY trial. Kenneth W,Mahaffey,James JF. American Heart Journal . 2005
[8]  
Statin therapy is as-sociated with lower mortality among patients with severeheart failure. Mozaffarian D,Nye R,Levy WC. The American Journal of Cardiology . 2004
[9]  
Cholesteroland Recurrent Events Trial Investigators,The effect ofpravastatin on coronary events after myocardial infarc-tion in patients with average cholesterol levels. Sacks FM,Pfeffer MA,Moye LA,et al. The New England Journal of Medicine . 1996
[10]  
A cost-effectiveness a-nalysis of combination antiplatelet therapy for High-RiskAcute Coronary Sydrome clopidogrel plus Aspirin versusAspirin alone. Schleinitz MD,Heidenreich PA. Annals of Internal Medicine . 2005